JPMorgan Chase Financial Co. LLC Files 424B2 Prospectus

TL;DR

**JPMorgan Chase Financial Co. LLC just filed a prospectus for new securities, get ready for potential debt offerings.**

AI Summary

JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., filed a 424B2 prospectus on March 24, 2026, for an offering under its existing shelf registration statement (File No. 333-270004-01). This filing indicates that JPMorgan Chase Financial Co. LLC is preparing to offer new securities, likely debt, to raise capital. For investors, this means potential new investment opportunities in JPMorgan Chase-backed securities and signals the company's ongoing capital management strategy, which could impact its financial health and future stock performance.

Why It Matters

This filing signals JPMorgan Chase Financial Co. LLC's intent to issue new securities, which could provide capital for growth or refinancing, impacting the parent company's financial structure and future profitability.

Risk Assessment

Risk Level: medium — While a prospectus filing itself isn't high risk, the details of the actual securities offered (not yet specified here) could introduce market, interest rate, or credit risks.

Analyst Insight

An investor should monitor subsequent filings from JPMorgan Chase Financial Co. LLC for the specific terms (e.g., interest rates, maturity dates) of the securities being offered, as these details will determine the investment opportunity and potential impact on the parent company, JPMORGAN CHASE & CO.

Key Numbers

• 2026-03-24 — Filing Date (Date the 424B2 prospectus was filed by JPMorgan Chase Financial Co. LLC)
• 333-270004-01 — Shelf Registration File No. (The registration statement under which JPMorgan Chase Financial Co. LLC is offering securities)

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMORGAN CHASE & CO (company) — Parent company of the filer
• 0001665650 (person) — CIK of JPMorgan Chase Financial Co. LLC
• 0000019617 (person) — CIK of JPMORGAN CHASE & CO
• 333-270004-01 (dollar_amount) — File number for JPMorgan Chase Financial Co. LLC's shelf registration
• 333-270004 (dollar_amount) — File number for JPMORGAN CHASE & CO's shelf registration
• 2026-03-24 (dollar_amount) — Filing date of the 424B2 prospectus

Forward-Looking Statements

• JPMorgan Chase Financial Co. LLC will announce specific terms for a new securities offering. (JPMorgan Chase Financial Co. LLC) — high confidence, target: 2026-06-24

FAQ

Key Financial Figures

• $525,000 — l Company LLC Structured Investments $525,000 Auto Callable Contingent Interest Not
• $1,000 — f the notes. Minimum denominations of $1,000 and integral multiples thereof The no
• $7.25 — roceeds to Issuer Per note $1,000 $7.25 $992.75 Total $525,000 $3,806.2
• $992.75 — to Issuer Per note $1,000 $7.25 $992.75 Total $525,000 $3,806.25 $521,1
• $3,806.25 — $7.25 $992.75 Total $525,000 $3,806.25 $521,193.75 (1) See "Supplemental U
• $521,193.75 — 992.75 Total $525,000 $3,806.25 $521,193.75 (1) See "Supplemental Use of Proceeds
• $967.80 — en the terms of the notes were set, was $967.80 per $1,000 principal amount note. See "
• $0.01 — stock of Oracle Corporation, par value $0.01 per share (Bloomberg ticker: ORCL). We
• $15.3333 — a Contingent Interest Payment equal to $15.3333 (equivalent to a Contingent Interest Ra
• $74.84 — : 50.00% of the Initial Value, which is $74.84 Pricing Date: March 20, 2026 Origin
• $149.68 — ce Stock on the Pricing Date, which was $149.68 Final Value: The closing price of one
• $276.0000 — tal Contingent Interest Payments 18 $276.0000 17 $260.6667 16 $245.3333 15
• $260.6667 — terest Payments 18 $276.0000 17 $260.6667 16 $245.3333 15 $230.0000 14
• $245.3333 — 18 $276.0000 17 $260.6667 16 $245.3333 15 $230.0000 14 $214.6667 13
• $230.0000 — 17 $260.6667 16 $245.3333 15 $230.0000 14 $214.6667 13 $199.3333 12

Filing Documents

• form424b2.htm (424B2) — 172KB
• exfilingfees.htm (EX-FILING FEES) — 5KB
• image_001.jpg (GRAPHIC) — 21KB
• image_002.jpg (GRAPHIC) — 5KB
• image_006.jpg (GRAPHIC) — 134KB
• image_003.gif (GRAPHIC) — 5KB
• image_004.gif (GRAPHIC) — 5KB
• image_005.gif (GRAPHIC) — 5KB
• 0001918704-26-007930.txt ( ) — 506KB
• exfilingfees_htm.xml (XML) — 2KB

From the Filing

SUPPLEMENT March 20, 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(2) JPMorgan Chase Financial Company LLC Structured Investments $525,000 Auto Callable Contingent Interest Notes Linked to the Common Stock of Oracle Corporation due September 23, 2027 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek a Contingent Interest Payment with respect to each Review Date for which the closing price of one share of the Reference Stock is greater than or equal to 50.00% of the Initial Value, which we refer to as the Interest Barrier. The notes will be automatically called if the closing price of one share of the Reference Stock on any Review Date (other than the first, second, third, fourth, fifth and final Review Dates) is greater than or equal to the Initial Value. The earliest date on which an automatic call may be initiated is September 21, 2026. Investors should be willing to accept the risk of losing a significant portion or all of their principal and the risk that no Contingent Interest Payment may be made with respect to some or all Review Dates. Investors should also be willing to forgo fixed interest and dividend payments, in exchange for the opportunity to receive Contingent Interest Payments. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Minimum denominations of $1,000 and integral multiples thereof The notes priced on March 20, 2026 and are expected to settle on or about March 25, 2026. CUSIP: 46660RB52 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the accompanying product supplement and "Selected Risk Considerations" beginning on page PS-5 of this pricing supplement. Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $7.25 $992.75 Total $525,000 $3,806.25 $521,193.75 (1) See "Supplemental Use of Proceeds" in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $7.25 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See "Plan of Distribution (Conflicts of Interest)" in the accompanying product supplement. The estimated value of the notes, when the terms of the notes were set, was $967.80 per $1,000 principal amount note. See "The Estimated Value of the Notes" in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. Pricing supplement to product supplement no. 4-I dated April 13, 2023, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024 Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Reference Stock: The common stock of Oracle Corporation, par value $0.01 per share (Bloomberg ticker: ORCL). We refer to Oracle Corporation as "Oracle". Contingent Interest Payments: If the notes have not been automatically called and the closing price of one share of the Reference Stock on any Review Date is greater than or equal to the Interest Barrier, you will receive on the applicable Interest Payment Date for each $1,000 principal amount note a Contingent Interest Payment equal to $15.3333 (equivalent to a Contingent Interest Rate of 18.40% per annum, payable at a rate of 1.53333% per month). If the closing price of one share of the Reference Stock on any Review Date is less than the Interest Barrier, no Contingent Interest Payment will be made with respect to that Review Date. Contingent Interest Rate: 18.40% per annum, payable at a rate of 1.53333% per month Interest Barrier/Trigger Value: 50.00% of the Initial Value, which is $74.84 Pricing Date: March 20, 2026 Original

View Full Filing

View this 424B2 filing on SEC EDGAR